New York-based MetLife, Inc. (MET) is a global financial services company that provides life insurance, health and disability benefits, annuities, retirement solutions, and investment management services to individuals, businesses, and institutional clients. Valued at $46.4 billion by market cap, the company operates in more than 40 markets worldwide, with a strong presence in the United States, Asia, Latin America, Europe, and the Middle East. MetLife also offers
The global provider of insurance, annuities, and employee benefit programs is expected to announce its fiscal 2026 third-quarter earnings on Wednesday, Nov. 4 after the market closes. Ahead of the event, analysts expect MET to report a profit of $2.71 per share on a diluted basis, up 15.8% from $2.34 per share in the year-ago quarter. The company beat the consensus estimates in each of the last four quarters.
More Top Stocks Daily: Go behind Wall Street’s hottest headlines with Barchart’s Active Investor newsletter.
For the current year, analysts expect MET to report EPS of $9.94, up 11.8% from $8.89 in fiscal 2025. Its EPS is expected to rise 7.9% year over year to $10.72 in fiscal 2027.
www.barchart.comMET stock has outperformed the S&P 500 Index’s ($SPX) 13.1% gains over the past 52 weeks, with shares up 26.4% during this period. Similarly, it has outpaced the State Street Financial Select Sector SPDR ETF’s (XLF) 6.4% returns over the same time frame.
www.barchart.comMetLife has outpaced the broader market over the past year, reflecting investor confidence in the global insurer’s established market position and diversified financial services business. Over the past five years, net premiums earned increased by 2.7% annually, while earnings per share grew by 3.3% per year.
On Oct. 6, MetLife announced that its board of directors had declared a fourth-quarter 2026 cash dividend of $0.5925 per common share. The dividend is scheduled to be paid on December 8, 2026, to shareholders of record as of November 3, 2026. The declaration underscores MetLife’s ongoing commitment to returning capital to shareholders through regular dividend payments, providing investors with a source of income alongside potential share-price appreciation.
Analysts’ consensus opinion on MET stock is reasonably bullish, with a “Moderate Buy” rating overall. Out of 19 analysts covering the stock, 12 advise a “Strong Buy” rating, one suggests a “Moderate Buy,” and six give a “Hold.” MET’s average analyst price target is $108.76, indicating a potential upside of 10.1% from the current levels.
On the date of publication, Kritika Sarmah did not have (either directly or indirectly) positions in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
More news from Barchart
Micron’s Taiwan Unit Reached a Deal With the Taichung Union. Here’s What to Know. IBM’s CEO Just Issued a Warning Message on AI Spending. He Ended Up Hurting His Own Stock. What the New Class C Share Structure Actually Means for Meta Platforms Stock Investors Lockheed Vs. RTX: The Cheaper Defense Giant Is The Clear Value Win